The current study investigated the effects of cuprizone-induced demyelination and subsequent nanoformulation-based treatments on the expression of T-cell markers CD4 and CD8, which are key indicators of helper and cytotoxic T-cell activity, respectively. This evidence concerns the gene CD4 and Peripheral demyelination.